Belgium· BE-AMP-SAM661502-00

Vafseo 450 mg

A vadadustat product containing vadadustat, registered in Belgium by Akebia Europe. The same ATC class is registered in 13 of our 19 countries.

ATC B03XA08

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedVafseo 450 mgATCB03XA08REGISTER NO.BE-AMP-SAM661502-00PACKS LISTED0CHECKEDSeptember 26, 2026

Where it is registered

Vadadustat is registered in 13 of 19 countries.

Countries holding a registration under ATC B03XA08 (vadadustat), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 8 of them publish a price we can compare per daily dose

Vadadustat · ATC B03XA08

13 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of vadadustat costs, country by country.

Normalised to the WHO defined daily dose (0.3 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Vadadustat · price per daily dose (0.3 g)

USD · FX 28 Sept 2026

  • CH Switzerland$15.64
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Vadadustat
Manufacturer
Akebia Europe
Country
Belgium (BE)
ATC code
B03XA08
ATC class
Vadadustat
Defined daily dose
0.3 g, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/1b7d72cd-cce4-43f2-9810-a8cf8a34f7da
GET /v1/drugs/1b7d72cd-cce4-43f2-9810-a8cf8a34f7da?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Vafseo 450 mg",
  "name_fr": "Vafseo 450 mg",
  "name_nl": "Vafseo 450 mg",
  "amp_code": "SAM661502-00",
  "strengths": [
    "450.0000",
    "450.0000"
  ],
  "pack_count": 2,
  "substances": [
    "Vadadustat",
    "Sodium Starch Glycolate"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Vadadustat",
  "authorisation_numbers": [
    "EU/1/23/1725/005",
    "EU/1/23/1725/006"
  ]
}

See everything about vadadustat.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.